Organon & Co (OGN)

NYSE HEALTHCARE
$13.43 +0.07% RSI 72 Overbought Add Alert

Moving Averages

SMA 200
$8.99
Price above

Company Profile

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Market Cap
$3.53B
P/E Ratio
14.46
EPS
$0.93
Beta
1.544
Dividend Yield
0.60%
52-Week High
$13.49
52-Week Low
$5.68

Similar stocks in DRUG MANUFACTURERS - GENERAL

LLY
Lilly(Eli) & Company
RSI 55.0
PFE
Pfizer Inc
RSI 38.0
JNJ
Johnson & Johnson
RSI 50.0
BMY
Bristol-Myers Squibb Company
RSI 42.0
MRK
Merck & Co Inc
RSI 49.0
NVO
Novo Nordisk
RSI 61.0
ABBV
Abbvie Inc
RSI 62.0
GILD
Gilead Sciences Inc
RSI 43.0
AMGN
AMGEN Inc
RSI 47.0
GSK
GSK Plc
RSI 45.0

Data last updated: June 13, 2026 at 4:40 AM EDT

Track OGN for free

Get e-mail RSI alerts when Organon & Co enters oversold or overbought territory. Free forever.

Add Alert